Abbott (ABT) Receives FDA Approval for TactiFlex Ablation Catheter for Treatment of Abnormal Heart Rhythm streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the company s TactiFlex™ Ablation Catheter,.